SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000950137-05-014941
Filing Date
2005-12-14
Accepted
2005-12-14 15:58:04
Documents
12
Period of Report
2005-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-K a15283e10vk.htm 10-K 885452
2 EXHIBIT 10.4 a15283exv10w4.txt EX-10.4 273670
3 EXHIBIT 10.21 a15283exv10w21.txt EX-10.21 74568
4 EXHIBIT 10.23 a15283exv10w23.txt EX-10.23 85522
5 EXHIBIT 10.25 a15283exv10w25.txt EX-10.25 9826
6 EXHIBIT 21.1 a15283exv21w1.htm EX-21.1 2003
7 EXHIBIT 23.1 a15283exv23w1.htm EX-23.1 1702
8 EXHIBIT 31.1 a15283exv31w1.htm EX-31.1 7727
9 EXHIBIT 31.2 a15283exv31w2.htm EX-31.2 7760
10 EXHIBIT 32.1 a15283exv32w1.htm EX-32.1 3637
11 EXHIBIT 32.2 a15283exv32w2.htm EX-32.2 3673
12 GRAPHIC a15283a1528301.gif GRAPHIC 18902
  Complete submission text file 0000950137-05-014941.txt   1383411
Mailing Address 11388 SORRENTO VALLEY ROAD SUITE 200 SAN DIEGO CA 92121
Business Address 11388 SORRENTO VALLEY ROAD STE 200 SAN DIEGO CA 92121 8586225200
AVANIR PHARMACEUTICALS (Filer) CIK: 0000858803 (see all company filings)

IRS No.: 330314804 | State of Incorp.: CA | Fiscal Year End: 0930
Type: 10-K | Act: 34 | File No.: 001-15803 | Film No.: 051263903
SIC: 2834 Pharmaceutical Preparations